Linagliptin Impurity D(666816-91-7)
- Name: Linagliptin Impurity D
- Synonyms:3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert.-butyloxycarbonylamino)-piperidin-1-yl]-xanthine;Linagliptin Impurity D;3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butyloxycarbonylamino)-piperidin-1-yl]-3,7-dihydro-1H-purine-2,6-dione;3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butyloxycarbonylamino)-piperidin-1-yl]-xanthine;3-methyl-7-(but-2-yn-1-yl)-8-[(R)-3-(tert-butyloxycarbonylamino)-piperidin-1-yl]-xanthine;3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butyloxycarbonyl-amino)-piperidin-1-yl]-xanthine;Linagliptin Impurity 21;3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-tert-butoxycarbonylaminopiperidin-1-yl)-xanthine;3-methyl-7-(2-butyn-1-yl)-8-[(R)-3-(tert-butyloxycarbonylamino)-piperidin-1-yl]-2,6-dioxo-2,3,6,7-tetrahydro-1H-purine;Linagliptin impurity;Carbamic acid,[(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester;Linagliptin;
- Molecular Formula:C20H28N6O4
- Molecular Weight:416.47400
- CAS Registry Number:666816-91-7
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.666816-91-7 tert-butyl N-[(3R)-1-[7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-1H-purin-8-yl]piperidin-3-yl]carbamate
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.666816-91-7 tert-butyl (R)-(1-(7-(but-2-yn-1-yl)-3-methyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)piperidin-3-yl)carbamate
Assay:NLT 98% Appearance:White powder Package:Aluminum bag Storage:Room temperature Transportation:By air Application:Used in producing API
Min. Order:0
Supplier:Hangzhou Huarong Pharm Co., Ltd. [
China (Mainland)] CAS No.666816-91-7 Linagliptin Impurity D
Assay:95%+HPLC Application:Pharm intermediate
Min. Order:0
Supplier:HANGZHOU TIANYE CHEMICALS CO., LTD. [
China (Mainland)] CAS No.666816-91-7 Linagliptin Impurity D
Assay:95%+ or 98%+ Appearance:solid Package:10mg/25mg/50mg/100mg/1000mg/5000mg Storage:short-term storage normal temperature. long-term storage 2-8 鈩?nbsp;Transportation:express and sea transport and air freight Application:for drug impurity for drug standards,for drug research and development銆侱rug impurity reference, drug standard, analytical chemistry, standard substance, organic chemical synthesis, chemical custo...
Min. Order:25Milligram
Supplier:Hubei Moxin Biotechnology Co., Ltd [
China (Mainland)] CAS No.666816-91-7 Linagliptin Impurity D
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:Linagliptin Impurity D
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.666816-91-7 Carbamic acid,[(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
Assay:97% Appearance:Powder or liquid Package:According to customer Storage:Store in a tightly closed container, in a cool and dry place. Transportation:Fedex,DHL,TNT,BY SEA and BY AIR Application:Medicinal Chemistry Biomedicine Pharmaceutical intermediates Chemistry experiment Biological experiments Chemical reagent For R&D use only.
Min. Order:10Milligram
Supplier:Amadis Chemical Co., Ltd. [
China (Mainland)] CAS No.666816-91-7 Linagliptin Impurity D
Assay:> 95% Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 66678-78-2/1,3,5-Triazin-2(1H)-one, 4-amino-5,6-dihydro-5-methyl-
- 66678-79-3/1,3,5-Triazin-2(1H)-one, 1-ethyl-3,6-dihydro-4-[(trimethylsilyl)oxy]-
- 66678-83-9/1,3,5-Triazin-2(1H)-one, 1-butyl-3,6-dihydro-4-[(trimethylsilyl)oxy]-
- 66679-00-3/1,2-Benzenediol, 4-(2-pyridinylazo)-
- 66679-29-6/Pentanoic acid, 4,5-dihydroxy-
- 66679-38-7/7H-Purine-7-butanenitrile, 1,2,3,6-tetrahydro-b-hydroxy-1,3-dimethyl-2,6-dioxo-
- 66679-56-9/Benzamide, N,N'-1,2-phenylenebis[4-methoxy-
- 66679-65-0/2,4(1H,3H)-Quinazolinedione, 3-(4-methylphenyl)-, 2-hydrazone
- 66679-74-1/2,4(1H,3H)-Quinazolinedione, 3-(4-chlorophenyl)-, 2-hydrazone
- 66680-05-5/Benzaldehyde, 4-(dimethylamino)-, (1,4-dihydro-4-oxo-2-quinazolinyl)hydrazone
- 66680-81-7/Benzenemethanol, a-phenyl-, formate
- 66680-84-0/CIS-TRI-N-BUTYL(1-PROPENYL)TIN
- 66680-85-1/Stannane, tributyl-1-propenyl-, (E)-
- 66680-86-2/2-METHYLPROPENE-1-TRIBUTYLSTANNANE
- 66680-87-3/Stannane, tributyl[(1Z)-2-phenylethenyl]-
- 66680-88-4/Stannane, tributyl(2-phenylethenyl)-, (E)-
- 666816-87-1/1H-Purine-2,6-dione, 1-[2-(2-aminophenyl)-2-oxoethyl]-8-bromo-7-(2E)-2-butenyl-3,7-dihydro- 3-methyl-
- 666816-88-2/Carbamic acid, [1-[1-[2-(2-aminophenyl)-2-oxoethyl]-7-(2-butynyl)-2,3,6,7-tetrahydro-3- methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-89-3/Carbamic acid, [(3R)-1-[7-(2E)-2-butenyl-2,3,6,7-tetrahydro-3-methyl-1-[2-(2-nitrophenyl )-2-oxoethyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-91-7/Linagliptin Impurity D
- 666816-92-8/Carbamic acid, [(3S)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-2,6-dioxo-1H-purin-8- yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-93-9/Carbamic acid, [1-[1-[2-(2-aminophenyl)-2-oxoethyl]-7-(2E)-2-butenyl-2,3,6,7-tetrahydro -3-methyl-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-96-2/Carbamic acid, [(3R)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[2-(2-nitrophenyl)-2- oxoethyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-97-3/Carbamic acid, [(3S)-1-[7-(2-butynyl)-2,3,6,7-tetrahydro-3-methyl-1-[2-(2-nitrophenyl)-2- oxoethyl]-2,6-dioxo-1H-purin-8-yl]-3-piperidinyl]-, 1,1-dimethylethyl ester
- 666816-98-4/8-bromo-7-(but-2-ynyl)-3-methyl-1H-purine-2,6(3H,7H)-dione
- 666816-99-5/1H-Purine-2,6-dione, 8-bromo-7-(2E)-2-butenyl-3,7-dihydro-3-methyl-
- 666817-12-5/1H-Benzimidazole-5-acetamide, 2-(5-chloro-2-thienyl)-N-[3-methyl-4-(3-oxo-4-morpholinyl)phenyl]-
- 666823-86-5/1,4-Etheno-1H-2,3-benzodiazepine-2,3-dicarboxylic acid, 6-(acetyloxy)-4,5-dihydro-4,7,8-trimethoxy-5-oxo-, diethyl ester
- 666823-87-6/1,4-Etheno-1H-2,3-benzodiazepine-2,3-dicarboxylic acid, 4,5-dihydro-4,7,8-trimethoxy-5-oxo-6-(1-oxopropoxy)-, diethyl ester
- 666823-88-7/1,4-Etheno-1H-2,3-benzodiazepine-2,3-dicarboxylic acid, 4,5-dihydro-4,7,8-trimethoxy-5-oxo-6-(1-oxobutoxy)-, diethyl ester